Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS)&amp;nbsp;for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial
Research Square (Research Square)